- Latest available (Revised)
- Point in Time (31/12/2020)
- Original (As adopted by EU)
Commission Implementing Regulation (EU) 2020/1397Show full title
Commission Implementing Regulation (EU) 2020/1397 of 5 October 2020 concerning the renewal of the authorisation of L-isoleucine produced by Escherichia coli FERM ABP-10641 as a nutritional additive, its extension of use and the authorisation of L-isoleucine produced by Corynebacterium glutamicum KCCM 80189 as a feed additive for all animal species, and repealing Regulation (EU) No 348/2010 (Text with EEA relevance)
You are here:
- Regulations originating from the EU
- 2020 No. 1397
- Annexes only
What Version
Advanced Features
- Show Geographical Extent(e.g. England, Wales, Scotland and Northern Ireland)
- Show Timeline of Changes
More Resources
Legislation originating from the EU
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
This item of legislation originated from the EU
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Changes over time for: Commission Implementing Regulation (EU) 2020/1397 (Annexes only)
Alternative versions:
Status:
Point in time view as at 31/12/2020.
Changes to legislation:
There are currently no known outstanding effects for the Commission Implementing Regulation (EU) 2020/1397.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
ANNEXU.K.
| a Details of the analytical methods are available at the following address of the Reference Laboratory: https://ec.europa.eu/jrc/en/eurl/feed-additives/evaluation-reports | |||||||||
| b Commission Regulation (EC) No 152/2009 of 27 January 2009 laying down the methods of sampling and analysis for the official control of feed (OJ L 54, 26.2.2009, p. 1). | |||||||||
| c Exposure calculated based on the endotoxin level and the dusting potential of the additive according to the method used by EFSA (EFSA Journal 2020;18(2):6022); analytical method: European Pharmacopoeia 2.6.14. (bacterial endotoxins). | |||||||||
| Identification number of the additive | Name of the holder of authorisation | Additive | Composition, chemical formula, description, analytical method. | Species or category of animal | Maximum age | Minimum content | Maximum content | Other provisions | End of period of authorisation |
|---|---|---|---|---|---|---|---|---|---|
| mg/kg of complete feed with a moisture content of 12 % | |||||||||
| Category: nutritional additives. Functional group: amino acids, their salts and analogues. | |||||||||
| 3c381 | - | L-isoleucine | Additive composition Powder with a minimum content of L-isoleucine of 93,4 % (on a dry matter basis) | All animal species | - | - | - | 1. L-isoleucine may be placed on the market and used as an additive consisting of a preparation. 2. In the directions for use of the additive and premixture, the storage conditions, the stability to heat treatment and in water shall be indicated. 3. The additive may be used via water for drinking. 4. Declaration to be made on the label of the additive and premixture:
5. The endotoxin content of the additive and its dusting potential shall ensure a maximal endotoxin exposure of 1 600 IU endotoxins/m3 air c. 6. For users of the additive and premixture, feed business operators shall establish operational procedures and organisational measures to address potential risks by inhalation. Where those risks cannot be eliminated or reduced to a minimum by such procedures and measures, the additive and premixture shall be used with personal protective equipment. | 26 October 2030 |
| Characterisation of the active substance L-isoleucine produced by fermentation with Escherichia coli FERM ABP-10641 IUPAC name: (2S,3S)-2-amino-3-methylpentanoic acid Chemical formula: C6H13NO2 CAS number: 73-32-5 | |||||||||
| Analytical method a For the identification of L-isoleucine in the feed additive:
For the quantification of isoleucine in the feed additive:
For the quantification of isoleucine in premixtures:
For the quantification of isoleucine in compound feed and feed materials:
For the quantification of isoleucine in water:
| |||||||||
| 3c383 | - | L-isoleucine | Additive composition Powder with a minimum content of L-isoleucine of 90 % | All animal species | - | - | - | 1. L-isoleucine may be placed on the market and used as an additive consisting of a preparation. 2. In the directions for use of the additive and premixture, the storage conditions, the stability to heat treatment and in water shall be indicated. 3. The additive may be used via water for drinking. 4. Declaration to be made on the label of the additive and premixture:
| 26 October 2030 |
| Characterisation of the active substance L-isoleucine produced by fermentation with Corynebacterium glutamicum KCCM 80189 IUPAC name: (2S,3S)-2-amino-3-methylpentanoic acid Chemical formula: C6H13NO2 CAS number: 73-32-5 | |||||||||
| Analytical method a For the identification of L-isoleucine in the feed additive:
For the quantification of isoleucine in the feed additive:
For the quantification of isoleucine in premixtures:
For the quantification of isoleucine in compound feed and feed materials:
For the quantification of isoleucine in water:
| |||||||||
| Category: Sensory additives. Functional group: Flavouring compounds | |||||||||
| 3c381 | - | L-isoleucine | Additive composition Powder with a minimum content of L-isoleucine of 93,4 % (on a dry matter basis) | All animal species | - | - | 1. L-isoleucine may be placed on the market and used as an additive consisting of a preparation. 2. The additive shall be incorporated into the feed in the form of a premixture. 3. In the directions for use of the additive and premixture, the storage conditions and the stability to heat treatment shall be indicated. 4. On the label of the additive the following shall be indicated: ‘Recommended maximum content of the active substance of complete feedingstuff with a moisture content of 12 %: 25 mg/kg.’ 5. The functional group, the identification number, the name and the added amount of the active substance shall be indicated on the label of the premixtures, if the following content of the active substance in complete feedingstuff with a moisture content of 12 % is exceeded: 25 mg/kg. 6. The endotoxin content of the additive and its dusting potential shall ensure a maximal endotoxin exposure of 1 600 IU endotoxins/m3 airc. 7. For users of the additive and premixture, feed business operators shall establish operational procedures and organisational measures to address potential by inhalation. Where those risks cannot be eliminated or reduced to a minimum by such procedures and measures, the additive and premixture shall be used with personal protective equipment. | 26 October 2030 | |
| Characterisation of the active substance L-isoleucine) produced by fermentation with Escherichia coli FERM ABP-10641 IUPAC name: (2S,3S)-2-amino-3-methylpentanoic acid Chemical formula: C6H13NO2 CAS number: 73-32-5 | |||||||||
| Analytical method a For the identification of L-isoleucine in the feed additive:
For the quantification of isoleucine in the feed additive:
For the quantification of isoleucine in premixtures:
| |||||||||
Options/Help
Print Options
PrintThe Whole Regulation
PrintThe Annexes only
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
See additional information alongside the content
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Opening Options
Different options to open legislation in order to view more content on screen at once
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the EU Official Journal
- lists of changes made by and/or affecting this legislation item
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
Timeline of Changes
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.